TOP TIERMARKET NEWSWIRE
News & sentiment

ARBUTUS BIOPHARMA CO (ABUS) — News & AI sentiment

ARBUTUS BIOPHARMA CO (ABUS) news roundup. 1 story in the past week, 15 over 30 days. Average 30-day sentiment is 59.5/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
1
avg sentiment 63/100
30d stories
15
avg sentiment 59.5/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

ABUS news in the last 24 hours, 7 days, 30 days and 90 days

How much ABUS coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowABUS storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days163/100ABUS headlines →
Last 30 days1559.5/100ABUS headlines →
Last 90 days2657.3/100ABUS headlines →

Latest stories on ABUS

1d ago
Aug 24
Aug 24
Aug 24
Aug 21
Aug 21
Why is Arbutus Biopharma stock surging today?
Investing.com Markets65 · bullishgeneral
Aug 21
Aug 21
Aug 21
Arbutus Biopharma Corp (ABUS) files 8-K
SEC 8-K50 · neutralgeneral
Aug 21
Aug 21
Aug 21
Aug 21
Aug 21
Aug 21
Aug 12
Arbutus Biopharma Corp (ABUS) files 8-K
SEC 8-K50 · neutralgeneral
Aug 12
Aug 12
Aug 12
Aug 11
Jul 16
Jul 16
Arbutus Biopharma Corp (ABUS) files 8-K
SEC 8-K50 · neutralgeneral
Jul 16
Jul 16
Jul 13
Open ABUS in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →